{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:11:17Z","timestamp":1790835077284,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The mechanism by which hypophosphataemia develops following kidney transplantation remains debated, and limited research is available regarding risk factors. This study aimed to assess the association between recipient and donor variables, and the severity of post-transplantation hypophosphataemia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We performed a single-centre retrospective observational study. We assessed the association between demographic, clinical and biochemical variables and the development of hypophosphataemia. We used linear regression analysis to assess association between these variables and phosphate nadir.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>87.6% of patients developed hypophosphataemia. Patients developing hypophosphataemia were younger, had a shorter time on renal replacement therapy, were less likely to have had a parathyroidectomy or to experience delayed graft function, were more likely to have received a living donor transplant, from a younger donor. They had higher pre-transplantation calcium levels, and lower alkaline phosphatase levels.<\/jats:p><jats:p>Receipt of a living donor transplant, lower donor age, not having had a parathyroidectomy, receiving a transplant during the era of tacrolimus-based immunosuppression, not having delayed graft function, higher pre-transplantation calcium, and higher pre-transplantation phosphate were associated with lower phosphate nadir by multiple linear regression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This analysis demonstrates an association between variables relating to better graft function and hypophosphataemia. The links with biochemical measures of mineral-bone disease remain less clear.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12882-021-02624-3","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T09:02:58Z","timestamp":1639040578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical factors associated with severe hypophosphataemia after kidney transplant"],"prefix":"10.1186","volume":"22","author":[{"given":"Maximilian R.","family":"Ralston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen S.","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick B.","family":"Mark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin C.","family":"Geddes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,9]]},"reference":[{"issue":"3","key":"2624_CR1","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2215\/CJN.09470819","volume":"15","author":"CD Miles","year":"2020","unstructured":"Miles CD, Westphal SG. Electrolyte disorders in kidney transplantation. Clin J Am Soc Nephrol. 2020;15(3):412\u20134.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"2624_CR2","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrneph.2015.153","volume":"11","author":"LC Baia","year":"2015","unstructured":"Baia LC, Heilberg IP, Navis G, de Borst MH. Phosphate and FGF-23 homeostasis after kidney transplantation. Nat Rev Nephrol. 2015;11(11):656\u201366.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"2624_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/01.mnh.0000203187.49890.cc","volume":"15","author":"H Ghanekar","year":"2006","unstructured":"Ghanekar H, Welch BJ, Moe OW, Sakhaee K. Post-renal transplantation hypophosphatemia: a review and novel insights. Curr Opin Nephrol Hypertens. 2006;15(2):97.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"2624_CR4","doi-asserted-by":"publisher","first-page":"231","DOI":"10.5500\/wjt.v5.i4.231","volume":"5","author":"PT Taweesedt","year":"2015","unstructured":"Taweesedt PT, Disthabanchong S. Mineral and bone disorder after kidney transplantation. World J Transplant. 2015;5(4):231\u201342.","journal-title":"World J Transplant"},{"issue":"Pt 6","key":"2624_CR5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1177\/0004563214521399","volume":"51","author":"P Manghat","year":"2014","unstructured":"Manghat P, Sodi R, Swaminathan R. Phosphate homeostasis and disorders. Ann Clin Biochem. 2014;51(Pt 6):631\u201356.","journal-title":"Ann Clin Biochem"},{"key":"2624_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3389\/fmed.2018.00261","volume":"5","author":"V Pochineni","year":"2018","unstructured":"Pochineni V, Rondon-Berrios H. Electrolyte and Acid-Base disorders in the renal transplant recipient. Front Med. 2018;5:261.","journal-title":"Front Med"},{"issue":"5","key":"2624_CR7","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1093\/ndt\/gfh128","volume":"19","author":"P Evenepoel","year":"2004","unstructured":"Evenepoel P, Claes K, Kuypers D, Maes B, Bammens B, Vanrenterghem Y. Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-Centre study. Nephrol Dial Transplant. 2004;19(5):1281\u20137.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"2624_CR8","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1046\/j.1523-1755.2001.00755.x","volume":"59","author":"M Levi","year":"2001","unstructured":"Levi M. Post-transplant hypophosphatemia. Kidney Int. 2001;59(6):2377\u201387.","journal-title":"Kidney Int"},{"issue":"3","key":"2624_CR9","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1046\/j.1523-1755.2001.0600031182.x","volume":"60","author":"J Green","year":"2001","unstructured":"Green J, Debby H, Lederer E, Levi M, Zajicek HK, Bick T. Evidence for a PTH-independent humoral mechanism in post-transplant hypophosphatemia and phosphaturia. Kidney Int. 2001;60(3):1182\u201396.","journal-title":"Kidney Int"},{"issue":"4","key":"2624_CR10","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/ki.1981.54","volume":"19","author":"RW Rosenbaum","year":"1981","unstructured":"Rosenbaum RW, Hruska KA, Korkor A, Anderson C, Slatopolsky E. Decreased phosphate reabsorption after renal transplantation: evidence for a mechanism independent of calcium and parathyroid hormone. Kidney Int. 1981;19(4):568\u201378.","journal-title":"Kidney Int"},{"issue":"8","key":"2624_CR11","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1097\/TP.0b013e318264fc08","volume":"94","author":"X Barros","year":"2012","unstructured":"Barros X, Torregrosa JV, Mart\u00ednez de Osaba MJ, Casals G, Paschoalin R, Dur\u00e1n CE, et al. Earlier decrease of FGF-23 and less hypophosphatemia in preemptive kidney transplant recipients. Transplantation. 2012;94(8):830\u20136.","journal-title":"Transplantation."},{"issue":"3","key":"2624_CR12","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.kint.2016.04.024","volume":"90","author":"NA Dhayat","year":"2016","unstructured":"Dhayat NA, Ackermann D, Pruijm M, Ponte B, Ehret G, Guessous I, et al. Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function. Kidney Int. 2016;90(3):648\u201357.","journal-title":"Kidney Int"},{"issue":"7","key":"2624_CR13","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1681\/ASN.2005010052","volume":"16","author":"O Gutierrez","year":"2005","unstructured":"Gutierrez O, Isakova T, Rhee E, Shah A, Holmes J, Collerone G, et al. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol JASN. 2005;16(7):2205\u201315.","journal-title":"J Am Soc Nephrol JASN"},{"issue":"5","key":"2624_CR14","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1159\/000107069","volume":"27","author":"K Miyamoto","year":"2007","unstructured":"Miyamoto K, Ito M, Tatsumi S, Kuwahata M, Segawa H. New aspect of renal phosphate reabsorption: the type IIc sodium-dependent phosphate transporter. Am J Nephrol. 2007;27(5):503\u201315.","journal-title":"Am J Nephrol"},{"issue":"9","key":"2624_CR15","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1016\/j.transproceed.2012.09.070","volume":"44","author":"AI S\u00e1nchez Fructuoso","year":"2012","unstructured":"S\u00e1nchez Fructuoso AI, Maestro ML, Calvo N, De La Orden V, P\u00e9rez Flores I, Vidaurreta M, et al. Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation. Transplant Proc. 2012;44(9):2551\u20134.","journal-title":"Transplant Proc"},{"issue":"3","key":"2624_CR16","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2009","unstructured":"Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res. 2009;19(3):429\u201335.","journal-title":"J Bone Miner Res"},{"issue":"8","key":"2624_CR17","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1038\/sj.ki.5001788","volume":"70","author":"I Bhan","year":"2006","unstructured":"Bhan I, Shah A, Holmes J, Isakova T, Gutierrez O, Burnett S-A, et al. Post-transplant hypophosphatemia: tertiary \u2018hyper-Phosphatoninism\u2019? Kidney Int. 2006;70(8):1486\u201394.","journal-title":"Kidney Int"},{"issue":"2","key":"2624_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.semnephrol.2012.12.019","volume":"33","author":"P Evenepoel","year":"2013","unstructured":"Evenepoel P. Recovery versus persistence of disordered mineral metabolism in kidney transplant recipients. Semin Nephrol. 2013;33(2):191\u2013203.","journal-title":"Semin Nephrol"},{"issue":"5","key":"2624_CR19","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1111\/j.1600-6143.2007.01753.x","volume":"7","author":"P Evenepoel","year":"2007","unstructured":"Evenepoel P, Naesens M, Claes K, Kuypers D, Vanrenterghem Y. Tertiary \u2018Hyperphosphatoninism\u2019 accentuates hypophosphatemia and suppresses Calcitriol levels in renal transplant recipients. Am J Transplant. 2007;7(5):1193\u2013200.","journal-title":"Am J Transplant"},{"issue":"6","key":"2624_CR20","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.2215\/CJN.01310308","volume":"3","author":"P Evenepoel","year":"2008","unstructured":"Evenepoel P, Meijers BKI, de Jonge H, Naesens M, Bammens B, Claes K, et al. Recovery of Hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation. Clin J Am Soc Nephrol. 2008;3(6):1829\u201336.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"2624_CR21","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.ecl.2007.07.009","volume":"36","author":"N Hamdy","year":"2007","unstructured":"Hamdy N. Calcium and bone metabolism pre- and post-kidney transplantation. Endocrinol Metab Clin N Am. 2007;36(4):923\u201335.","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"5","key":"2624_CR22","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/ckj\/sfw065","volume":"9","author":"N Prasad","year":"2016","unstructured":"Prasad N, Jaiswal A, Agarwal V, Kumar S, Chaturvedi S, Yadav S, et al. FGF23 is associated with early post-transplant hypophosphataemia and normalizes faster than iPTH in living donor renal transplant recipients: a longitudinal follow-up study. Clin Kidney J. 2016;9(5):669\u201376.","journal-title":"Clin Kidney J"},{"issue":"5","key":"2624_CR23","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1530\/EJE-10-1150","volume":"164","author":"A Trombetti","year":"2011","unstructured":"Trombetti A, Richert L, Hadaya K, Graf J-D, Herrmann FR, Ferrari SL, et al. Early post-transplantation hypophosphatemia is associated with elevated FGF-23 levels. Eur J Endocrinol. 2011;164(5):839\u201347.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2624_CR24","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/S0041-1345(03)00765-6","volume":"35","author":"K Falkiewicz","year":"2003","unstructured":"Falkiewicz K, Nahaczewska W, Boratynska M, Owczarek H, Klinger M, Kaminska D, et al. Tacrolimus decreases tubular phosphate wasting in renal allograft recipients. Transplant Proc. 2003;35(6):2213\u20135.","journal-title":"Transplant Proc"},{"issue":"1","key":"2624_CR25","first-page":"62","volume":"5","author":"RM Higgins","year":"1990","unstructured":"Higgins RM, Richardson AJ, Endre ZH, Frostick SP, Morris PJ. Hypophosphataemia after renal transplantation: relationship to immunosuppressive drug therapy and effects on muscle detected by 31P nuclear magnetic resonance spectroscopy. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 1990;5(1):62\u20138.","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"issue":"2","key":"2624_CR26","first-page":"378","volume":"16","author":"C Schwarz","year":"2001","unstructured":"Schwarz C, B\u00f6hmig GA, Steininger R, Mayer G, Oberbauer R. Impaired phosphate handling of renal allografts is aggravated under rapamycin-based immunosuppression. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2001;16(2):378\u201382.","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"issue":"7","key":"2624_CR27","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1681\/ASN.2007020143","volume":"18","author":"SM Brunelli","year":"2007","unstructured":"Brunelli SM, Goldfarb S. Hypophosphatemia: clinical consequences and management. J Am Soc Nephrol. 2007;18(7):1999\u20132003.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"2624_CR28","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.transproceed.2011.12.050","volume":"44","author":"YJ Kim","year":"2012","unstructured":"Kim YJ, Kim MG, Jeon HJ, Ro H, Park HC, Jeong JC, et al. Clinical manifestations of hypercalcemia and hypophosphatemia after kidney transplantation. Transplant Proc. 2012;44(3):651\u20136.","journal-title":"Transplant Proc"},{"issue":"2","key":"2624_CR29","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1681\/ASN.V132551","volume":"13","author":"A Torres","year":"2002","unstructured":"Torres A, Lorenzo V, Salido E. Calcium metabolism and skeletal problems after transplantation. J Am Soc Nephrol. 2002;13(2):551\u20138.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2624_CR30","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s11914-008-0024-6","volume":"6","author":"ME Doyle","year":"2008","unstructured":"Doyle ME, Jan de Beur SM. The skeleton: endocrine regulator of phosphate homeostasis. Curr Osteoporos Rep. 2008;6(4):134\u201341.","journal-title":"Curr Osteoporos Rep"},{"issue":"25","key":"2624_CR31","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1056\/NEJMoa067411","volume":"357","author":"H Ekberg","year":"2007","unstructured":"Ekberg H, Tedesco-Silva H, Demirbas A, V\u00edtko S, Nashan B, G\u00fcrkan A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med. 2007;357(25):2562\u201375.","journal-title":"N Engl J Med"},{"issue":"1","key":"2624_CR32","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995;57(1):289\u2013300.","journal-title":"J R Stat Soc Ser B Methodol"},{"key":"2624_CR33","volume-title":"Introduction to bivariate and multivariate analysis","author":"RH Lindeman","year":"1980","unstructured":"Lindeman RH, Merenda PF, Gold RZ. Introduction to bivariate and multivariate analysis. Glenview: Scott Foresman; 1980."},{"issue":"4","key":"2624_CR34","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.transproceed.2007.03.025","volume":"39","author":"M Ramezani","year":"2007","unstructured":"Ramezani M, Einollahi B, Asl MA, Nafar M, Pourfarziani V, Moradi M, et al. Calcium and phosphorus metabolism disturbances after renal transplantation. Transplant Proc. 2007;39(4):1033\u20135.","journal-title":"Transplant Proc"},{"issue":"7","key":"2624_CR35","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1016\/j.transproceed.2003.08.056","volume":"35","author":"S Seifi","year":"2003","unstructured":"Seifi S, Pezeshki ML, Khatami MR, Mazdeh MM, Ahmadi F, Maziar S. Post\u2013renal transplantation hypophosphatemia. Transplant Proc. 2003;35(7):2645\u20136.","journal-title":"Transplant Proc"},{"issue":"8","key":"2624_CR36","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.2215\/CJN.10270916","volume":"12","author":"M van Londen","year":"2017","unstructured":"van Londen M, Aarts BM, Deetman PE, van der Weijden J, Eisenga MF, Navis G, et al. Post-transplant hypophosphatemia and the risk of death-censored graft failure and mortality after kidney transplantation. Clin J Am Soc Nephrol CJASN. 2017;12(8):1301\u201310.","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"1","key":"2624_CR37","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/TP.0000000000000823","volume":"100","author":"M Wolf","year":"2016","unstructured":"Wolf M, Weir MR, Kopyt N, Mannon RB, Visger JV, Deng H, et al. A prospective cohort study of mineral metabolism after kidney transplantation. Transplantation. 2016;100(1):184.","journal-title":"Transplantation."},{"issue":"4","key":"2624_CR38","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1093\/ckj\/sfaa061","volume":"14","author":"J Chevarria","year":"2021","unstructured":"Chevarria J, Sexton DJ, Murray SL, Adeel CE, O\u2019Kelly P, Williams YE, et al. Calcium and phosphate levels after kidney transplantation and long-term patient and allograft survival. Clin Kidney J. 2021;14(4):1106\u201313.","journal-title":"Clin Kidney J"},{"issue":"1","key":"2624_CR39","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1046\/j.1532-5415.2002.50002.x","volume":"50","author":"H-U Meier-Kriesche","year":"2002","unstructured":"Meier-Kriesche H-U, Cibrik DM, Ojo AO, Hanson JA, Magee JC, Rudich SM, et al. Interaction between donor and recipient age in determining the risk of chronic renal allograft failure. J Am Geriatr Soc. 2002;50(1):14\u20137.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"2624_CR40","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1093\/ndt\/14.4.930","volume":"14","author":"F Moreso","year":"1999","unstructured":"Moreso F, Ser\u00f3n D, Gil-Vernet S, Riera L, Fulladosa X, Ramos R, et al. Donor age and delayed graft function as predictors of renal allograft survival in rejection-free patients. Nephrol Dial Transplant. 1999;14(4):930\u20135.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"2624_CR41","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.transproceed.2009.01.064","volume":"41","author":"L Resende","year":"2009","unstructured":"Resende L, Guerra J, Santana A, Mil-Homens C, Abreu F, da Costa AG. Impact of donor age on renal allograft function and survival. Transplant Proc. 2009;41(3):794\u20136.","journal-title":"Transplant Proc"},{"issue":"4","key":"2624_CR42","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/01.TP.0000048381.48473.D1","volume":"75","author":"AK Mandal","year":"2003","unstructured":"Mandal AK, Snyder JJ, Gilbertson DT, Collins AJ, Silkensen JR. Does cadaveric donor renal transplantation ever provide better outcomes than live-donor renal transplantation?1,2. Transplantation. 2003;75(4):494.","journal-title":"Transplantation."},{"issue":"2","key":"2624_CR43","first-page":"119","volume":"10","author":"D Benavente","year":"2012","unstructured":"Benavente D, Chue CD, Moore J, Addison C, Borrows R, Ferro CJ. Serum phosphate measured at 6 and 12 months after successful kidney transplant is independently associated with subsequent graft loss. Exp Clin Transplant Off J Middle East Soc Organ Transplant. 2012;10(2):119\u201324.","journal-title":"Exp Clin Transplant Off J Middle East Soc Organ Transplant"},{"issue":"7","key":"2624_CR44","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1097\/TP.0b013e31819cd122","volume":"87","author":"GM Connolly","year":"2009","unstructured":"Connolly GM, Cunningham R, McNamee PT, Young IS, Maxwell AP. Elevated serum phosphate predicts mortality in renal transplant recipients. Transplantation. 2009;87(7):1040\u20134.","journal-title":"Transplantation."},{"issue":"10","key":"2624_CR45","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1111\/tri.12145","volume":"26","author":"L Huber","year":"2013","unstructured":"Huber L, Naik M, Budde K. Frequency and long-term outcomes of post-transplant hypophosphatemia after kidney transplantation. Transpl Int. 2013;26(10):e94\u20136.","journal-title":"Transpl Int"},{"issue":"4","key":"2624_CR46","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2215\/CJN.07090716","volume":"12","author":"HJ Jeon","year":"2017","unstructured":"Jeon HJ, Kim YC, Park S, Kim CT, Ha J, Han DJ, et al. Association of Serum Phosphorus Concentration with mortality and graft failure among kidney transplant recipients. Clin J Am Soc Nephrol CJASN. 2017;12(4):653\u201362.","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"3","key":"2624_CR47","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1053\/j.ajkd.2017.04.014","volume":"70","author":"B Merhi","year":"2017","unstructured":"Merhi B, Shireman T, Carpenter MA, Kusek JW, Jacques P, Pfeffer M, et al. Serum phosphorus and risk of cardiovascular disease, all-cause mortality, or graft failure in kidney transplant recipients: an ancillary study of the FAVORIT trial cohort. Am J Kidney Dis Off J Natl Kidney Found. 2017;70(3):377\u201385.","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"9","key":"2624_CR48","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s10157-019-01756-z","volume":"23","author":"K Nakai","year":"2019","unstructured":"Nakai K, Mitsuiki K, Kuroki Y, Nishiki T, Motoyama K, Nakano T, et al. Relative hypophosphatemia early after transplantation is a predictor of good kidney graft function. Clin Exp Nephrol. 2019;23(9):1161\u20138.","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"2624_CR49","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.transproceed.2011.11.046","volume":"44","author":"SY Han","year":"2012","unstructured":"Han SY, Hwang EA, Park SB, Kim HC, Kim HT. Elevated fibroblast growth factor 23 levels as a cause of early post-renal transplantation hypophosphatemia. Transplant Proc. 2012;44(3):657\u201360.","journal-title":"Transplant Proc"},{"issue":"8","key":"2624_CR50","first-page":"2691","volume":"26","author":"H Kawarazaki","year":"2011","unstructured":"Kawarazaki H, Shibagaki Y, Fukumoto S, Kido R, Nakajima I, Fuchinoue S, et al. The relative role of fibroblast growth factor 23 and parathyroid hormone in predicting future hypophosphatemia and hypercalcemia after living donor kidney transplantation: a 1-year prospective observational study. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2011;26(8):2691\u20135.","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"issue":"3","key":"2624_CR51","first-page":"196","volume":"29","author":"A Negri","year":"2009","unstructured":"Negri A. FGF-23 in chronic kidney disease and kidney post-transplant patients. Nefrol Publicacion Of Soc Espanola Nefrol. 2009;29(3):196\u2013202.","journal-title":"Nefrol Publicacion Of Soc Espanola Nefrol"},{"issue":"1","key":"2624_CR52","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1399-3046.2010.01405.x","volume":"15","author":"W Seeherunvong","year":"2010","unstructured":"Seeherunvong W, Wolf M. Tertiary excess of fibroblast growth factor 23 and hypophosphatemia following kidney transplantation. Pediatr Transplant. 2010;15(1):37\u201346.","journal-title":"Pediatr Transplant"},{"issue":"4","key":"2624_CR53","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.bone.2012.06.027","volume":"51","author":"K Tomida","year":"2012","unstructured":"Tomida K, Hamano T, Ichimaru N, Fujii N, Matsui I, Nonomura N, et al. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation. Bone. 2012;51(4):729\u201336.","journal-title":"Bone."},{"issue":"11","key":"2624_CR54","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1007\/s00467-010-1565-3","volume":"25","author":"J Silver","year":"2010","unstructured":"Silver J, Naveh-Many T. FGF23 and the parathyroid glands. Pediatr Nephrol Berl Ger. 2010;25(11):2241\u20135.","journal-title":"Pediatr Nephrol Berl Ger"},{"issue":"7","key":"2624_CR55","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1681\/ASN.2009040427","volume":"21","author":"R Canalejo","year":"2010","unstructured":"Canalejo R, Canalejo A, Martinez-Moreno JM, Rodriguez-Ortiz ME, Estepa JC, Mendoza FJ, et al. FGF23 fails to inhibit uremic parathyroid glands. J Am Soc Nephrol JASN. 2010;21(7):1125\u201335.","journal-title":"J Am Soc Nephrol JASN"},{"issue":"4","key":"2624_CR56","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00467-012-2309-3","volume":"28","author":"LF Bonewald","year":"2013","unstructured":"Bonewald LF, Wacker MJ. FGF23 production by osteocytes. Pediatr Nephrol Berl Ger. 2013;28(4):563\u20138.","journal-title":"Pediatr Nephrol Berl Ger"},{"issue":"5","key":"2624_CR57","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/sdi.12772","volume":"32","author":"ME Rodr\u00edguez-Ortiz","year":"2019","unstructured":"Rodr\u00edguez-Ortiz ME, Pend\u00f3n-Ruiz de Mier MV, Rodr\u00edguez M. Parathyroidectomy in dialysis patients: indications, methods, and consequences. Semin Dial. 2019;32(5):444\u201351.","journal-title":"Semin Dial"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02624-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-021-02624-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02624-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T02:41:56Z","timestamp":1726281716000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-021-02624-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,9]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["2624"],"URL":"https:\/\/doi.org\/10.1186\/s12882-021-02624-3","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,9]]},"assertion":[{"value":"8 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental protocols were approved by the NHS Greater Glasgow and Clyde Information Governance Department and there was no requirement for individual patient consent. No additional administrative permissions were required to access this data. All methods were carried out in accordance with relevant guidelines and regulations. Data was anonymised prior to analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"407"}}